🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New publication online! 🚨 Using the more advanced measure of brain network resilience, we found that the brain network of PD donors was less resilient to node failure of the dorsal anterior insula, related to a global increase in α-synuclein. neurology.org/doi/10.1212/WN…

Excited to share our new review paper on the role of the cerebellum in #MultipleSclerosis! We explore structural damage and network disconnections in MS, shedding light on the little brain. 🧠📚 Menno Schoonheim sciencedirect.com/science/articl…

I am thankful for all the praise we have received about the DAAE Score since it's release two weeks ago. I have spoken with many people about integrating medication use and MRI data into future versions of this clinical tool for estimating patient risk of transition to secondary

Very nice article by Marco Meglio NeurologyLive® about the DAAE Score, our newly developed clinical tool for estimating risk of transition to secondary progressive multiple sclerosis bit.ly/3YPKqMp

Today we had a fantastic conversation with Tom Fuchs, of @AmsterdamUMC, who provided some background on the DAAE score and how this tool can be used in the #MS clinical practice. Stay tuned for the interview coming soon! 🧠🎥 MS Centrum Amsterdam Anatomy & Neurosciences

📹🫣 Here is a sneak peek at the interview that we did with Tom Fuchs, of @AmsterdamUMC, on how the DAAE score can be used as an effective and efficient tool in #MultipleSclerosis. #MS MS Centrum Amsterdam Anatomy & Neurosciences 🧠

Tom Fuchs, of @AmsterdamUMC, talked about the key predictors used in the DAAE score for assessing the risk of transition to secondary progressive #MS. MS Centrum Amsterdam Anatomy & Neurosciences neurologylive.com/view/developme…

So many insightful sessions about cognition in multiple sclerosis at the IMSCOGS conference in Bern, Switzerland! The experience of learning from the experts, pictured here.

Just published! Cognition in people with multiple sclerosis can worsen silently in periods without relapse. Objective testing can help us capture and understand this change. Thank you to ECTRIMS for their support, to IMSCOGS for featuring this research in Bern Switzerland, and

Thank you to Carmen Tur and Emilio Portaccio for their very nice editorial in MSJ about our work on cognitive progression independent of relapse in people with multiple sclerosis. In the article, Drs. Tur and Portaccio make interesting points and observations about

🗣️🎙️In our latest NeuroVoices, Tom Fuchs, MD, PhD, of Amsterdam UMC, talked about a tool that helps assess the likelihood of transitioning to secondary progressive #MS, allowing clinicians to make informed treatment decisions in a timely manner. 👉 neurologylive.com/view/neurovoic…